Increased visceral fat accumulation modifies the effect of insulin resistance on arterial stiffness and hypertension risk

Nutr Metab Cardiovasc Dis. 2021 Feb 8;31(2):506-517. doi: 10.1016/j.numecd.2020.09.031. Epub 2020 Oct 15.

Abstract

Background and aims: Both insulin resistance (IR) and visceral adipose tissue (VAT) are related cardiometabolic risk factors; nevertheless, their joint effect on endothelial functionality is controversial. This study aims to evaluate the joint effect of IR and VAT on endothelial functionality using the pulse-waveform analysis and explore the mediating role of VAT on the effect of IR on arterial pressure, arterial stiffness and incident arterial hypertension.

Methods and results: We measured VAT (n = 586) using two methods (dual-energy X-ray absorptiometry and a clinical surrogate), arterial stiffness (with pulse-waveform velocity), and IR (using three methods: HOMA2-IR (n = 586), a frequently sampled intravenous glucose tolerance test (n = 131) and euglycemic hyperinsulinemic clamping (n = 97)) to confirm the mediator effect of IR on VAT. The incidence of arterial hypertension attributable to the mediating effect of IR related to VAT was evaluated using a prospective cohort (n = 6850). Adjusted linear regression models, causal mediation analysis, and Cox-proportional hazard risk regression models were performed to test our objective. IR and VAT led to increased arterial stiffness and increased blood pressure; the combination of both further worsened vascular parameters. Nearly, 57% (ΔE→MY 95% CI: 31.7-100.0) of the effect of IR on altered pulse-wave velocity (PWV) analysis was mediated through VAT. Moreover, VAT acts as a mediator of the effect of IR on increased mean arterial pressure (ΔE→MY 35.7%, 95% CI: 23.8-59) and increased hypertension risk (ΔE→MY 69.1%, 95% CI: 46.1-78.8).

Conclusion: VAT acts as a mediator of IR in promoting arterial stiffness and arterial hypertension. Both phenomena should be targeted to ameliorate the cardiometabolic risk.

Keywords: Cardiometabolic risk; Cardiovascular health; METS-VF; VAT.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adiposity*
  • Adult
  • Arterial Pressure*
  • Biomarkers / blood
  • Blood Glucose / metabolism
  • Cardiometabolic Risk Factors
  • Cross-Sectional Studies
  • Female
  • Humans
  • Hypertension / blood
  • Hypertension / diagnosis
  • Hypertension / epidemiology*
  • Hypertension / physiopathology
  • Incidence
  • Insulin / blood
  • Insulin Resistance*
  • Intra-Abdominal Fat / diagnostic imaging
  • Intra-Abdominal Fat / physiopathology*
  • Male
  • Mexico / epidemiology
  • Middle Aged
  • Prospective Studies
  • Risk Assessment
  • Vascular Stiffness*

Substances

  • Biomarkers
  • Blood Glucose
  • Insulin